期刊文献+

厄贝沙坦氢氯噻嗪治疗原发性高血压病疗效观察 被引量:3

暂未订购
导出
摘要 目的探讨厄贝沙坦氢氯噻嗪治疗原发性高血压病的临床疗效。方法 80例患者随机分为治疗组和对照组各40例。治疗组给予厄贝沙坦氢氯噻嗪片口服,每次1片,每天1次;对照组给予厄贝沙坦口服,每次150mg,每天1次。2组均持续用药8周。观察2组临床疗效及不良反应情况。结果治疗组总有效率为90.0%高于对照组的77.5%,差异有统计学意义(P<0.05);治疗组治疗后血压较治疗前下降,差异有统计学意义(P<0.05);2组均未见严重不良反应。结论厄贝沙坦氢氯噻嗪片治疗原发性高血压病疗效确切,作用时间长,耐受性良好,不良反应少,可以作为治疗高血压病的一线用药。
作者 修丽娟 李磊
出处 《临床合理用药杂志》 2010年第19期48-49,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献4

  • 1中国高血压防治指南修订委员会.2004年中国高血压防治指南(实本).高血压杂志,2004,12:483-486.
  • 2陈样新,傅国胜.血管紧张素Ⅱ及其受体与血管内皮功能的关系[J].临床心血管病杂志,2003,19(11):698-700. 被引量:28
  • 3Kaplan NM,Gifford RW.Choice of initial therapy for hypertension[J].JAMA,1996,275(20):1577.
  • 4Marrin M.Curent recommendation for the treatment of hypertension:are they still yalid[J].J Hypertens,2002,20(1):3-10.

二级参考文献18

  • 1Ruschitzka F T,Nall G, Lascher T F. The endothellum in coronary artery disease. Cardiology, 1997,88 : 3-- 19.
  • 2Rajagopalan S, Harrison D G. Reversing endothelial dysfuntion with ACE inhibitors: A new TREND? Circulation, 1996, 94:240--243.
  • 3Rajagopalan S, Kurz S, Munzcl T, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alternation of vasomotor tone. J Clin Invest, 1996,97 : 1916-- 1923.
  • 4Harrison D G. Endothelial control of vasomotion and nitric oxide production. Cardiol Clin, 1996,14 : 1-- 15.
  • 5Warnholtz A, Nickenig G, Schulz E, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis:evidence for the involvement of the rennin-angiotensin system. Circulation,1999, 99:2027--2033.
  • 6Vaughan D E. Fibrinolytic balance, the rennin-angiotensin system and atherosclerotic disease. Eur Heart J,1998,19 : G9-- G12.
  • 7Nishimura H, Tsuji H. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial calls. Thromb Haemostasis, 1999,82:1516--1521.
  • 8Morawietz H, Rueckschloss U. Angiotensin II induces LOX- 1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation, 1999, 100:899 --902.
  • 9Goodfield M B, Newby D E. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation, 1999,99:2983--2985.
  • 10Brown N J, Agirbasli M, Vaughan D E. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension, 1999,34:285--290.

共引文献27

同被引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部